We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 161 start-ups with an aggregate funding of $5.9b. The average funding per company in this subset is $85.1m.
Last update to the database: Feb 18, 2025. See changelog.
2
Funding Rounds
$15.6m
Money raised
Protera is a biotechnology company that works with protein engineering to address challenges in food, agriculture, the environment, and human health.
7
Funding Rounds
$254.1m
Money raised
Owkin is a medical treatment and therapeutics company founded by Thomas Clozel. They develop artificial intelligence and machine learning tools to augment and develop medical and biological research.
4
Funding Rounds
$49.6m
Money raised
Inato matches the right sites to the right clinical research study, globally.
9
Funding Rounds
$82.6m
Money raised
Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.
6
Funding Rounds
$427.1m
Money raised
DNA Script is a DNA synthesis company founded by Thomas Ybert, Sylvain Gariel, and Xavier Gordon in 2014, and headquartered in Paris, France.
4
Funding Rounds
$5.8m
Money raised
Motorika, a Russian developer and manufacturer of robotic functional traction and bionic arm prostheses for children and adults
3
Funding Rounds
$69.5m
Money raised
AI-powered drug discovery platform.
10
Funding Rounds
$62.4m
Money raised
A software solutions company providing bioinformatics solutions to life science and other sector
1
Funding Rounds
$1.4m
Money raised
A medical diagnostic products company focused on the diagnosis of cancers
1
Funding Rounds
$16.0m
Money raised
A pharmaceutical company that develops topical products to treat rare diseases
4
Funding Rounds
$72.0m
Money raised
ProteinSimple is a San Jose, California-based company founded in 2004.
14
Funding Rounds
$332.5m
Money raised
Enterome is a pharmaceutical company founded in 2012 by Pierre Belichard.
6
Funding Rounds
$94.2m
Money raised
Coave Therapeutics is a genetic medicines developer founded in 2014.
8
Funding Rounds
$59.9m
Money raised
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat diseases linked to imbalances in the intestinal microbiome.
5
Funding Rounds
$98.6m
Money raised
A biopharmaceutical company discovering and developing small molecules that target G protein-coupled receptors
6
Funding Rounds
$37.4m
Money raised
Developer of vaccines to provide broad-spectrum protection against highly mutating respiratory viruses.
5
Funding Rounds
$80.0m
Money raised
A diagnostics company focused on the discovery and development of diagnostic products for clinical laboratories for the management of oncology and genetic disorder.
9
Funding Rounds
$40.9m
Money raised
Pili is a biotechnology company using microorganisms fed sugar to synthesize commercial quality dyes.
1
Funding Rounds
$12.5m
Money raised
Clinical Research & Services
1
Funding Rounds
$3.4m
Money raised
Anagenesis Biotechnologies is a biotechnology company developing pre-clinical stem cell therapies for treating genetic and age-related muscle degenerative diseases.
4
Funding Rounds
$241.9m
Money raised
Asklepios Biopharmaceutical is a company in North Carolina.
8
Funding Rounds
$98.8m
Money raised
Decipher Biosciences is focused on utilizing genomic information to transform and improve cancer patient care by delivering accurate tests for determining the true nature of prostate and bladder cancers and enabling each patient to have a treatment plan based on the unique biology of their tumor.
3
Funding Rounds
$191.8m
Money raised
Diabeloop is a Grenoble-based company founded in 2015.
3
Funding Rounds
$6.5m
Money raised
Mojo provides fertility care through partnering tech experts with fertility experts.
5
Funding Rounds
$74.0m
Money raised
Depixus is an company of bioscientists based in Paris focusing in DNA research.
1
Funding Rounds
$1.2m
Money raised
Brainvectis is a biotechnology company developing treatments for neurodegenerative diseases through restoring cholesterol metabolism in the brain.
5
Funding Rounds
$5.9m
Money raised
Algama is a company that produces microalgae-based foods and ingredients for chemicals, cosmetics, nutrition, and health.
4
Funding Rounds
$179.5m
Money raised
Hifibio - High Fidelity Biology is a single cell technologies for drug discovery founded in 2013 by Liang Schweizer, Jeff He and Robert Nicol.
1
Funding Rounds
$4.0m
Money raised
Flash Therapeutics is a Toulouse-based biotechnology company founded in 2018.
2
Funding Rounds
$43.0m
Money raised
OTC Genetic Testing
6
Funding Rounds
$360.1k
Money raised
Platform that helps scientists understand cellular and molecular mechanisms to discover new drugs and therapies.
2
Funding Rounds
$30.8m
Money raised
A company developing a personalized treatment for oncology, neurology and psychiatry.
2
Funding Rounds
$97.5m
Money raised
Develops small molecules drug candidates in infectious & metabolic diseases and oncology
10
Funding Rounds
$254.4m
Money raised
Creating the future of tissue reconstruction with a novel platform of biomorphic programmable polymers.
3
Funding Rounds
$94.0m
Money raised
Volta Medical is an artificial intelligence to revolutionize interventional cardiac electrophysiology founded in 2016 by Théophile Mohr Durde, Julien Seitz and Jérome Kalifa.
2
Funding Rounds
$97.5m
Money raised
SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.
5
Funding Rounds
$97.7m
Money raised
Adionics is a Paris-based company.
8
Funding Rounds
$10.4m
Money raised
Abreos Biosciences is a lateral Flow Assays founded in 2013 by Bradley Messmer.
3
Funding Rounds
$54.0m
Money raised
Eyevensys is a clinical stage, private, biotechnology company that was founded in 2008.
1
Funding Rounds
$7.7m
Money raised
LNC Therapeutics is the 1st company to harness the therapeutic potential of Christensenella. We have been focused on the fundamental causes of illnesses
1
Funding Rounds
$2.4m
Money raised
Genomic Vision is a Bagneux, Marne-based company founded in 2005 by Aaron Bensimon.
3
Funding Rounds
$75.0m
Money raised
Stilla Technologies' NaicaTM System leverages the key assets of Crystal Digital PCRTM in a compact and reliable digital PCR solution with a single consumable
3
Funding Rounds
$157.3m
Money raised
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable.
3
Funding Rounds
$18.7m
Money raised
BIOMODEX develops and provides pre-operative training solutions for physicians based on 3D printing technology.
3
Funding Rounds
$30.8m
Money raised
PathoQuest is a Paris-based biotechnology company developing metagenomic tests for identification of pathogens.
4
Funding Rounds
$43.0m
Money raised
Therapixel is an artificial Intelligence for Medical Imaging founded in 2013 by Olivier Clatz.
1
Funding Rounds
$3.6m
Money raised
A company developing and manufacturing veterinary diagnostic and healthcare products for canine and feline
4
Funding Rounds
$14.3m
Money raised
A biotechnology company developing molecular diagnostic tests for autism and oncology.
1
Funding Rounds
$80.0m
Money raised
Alira Health is a Paris-based company founded in 1999 by Gabriele Brambilla.
4
Funding Rounds
$277.9m
Money raised
Immuno-modulatory antibodies
1
Funding Rounds
$3.2m
Money raised
Polyplus-Transfection S.A. is a transfection Supplies founded in 2001 by Anne Monjanel, Joelle Bloch, Patrick Metz and Paul Behr.
3
Funding Rounds
$313.8m
Money raised
InnovaFeed SAS is a French biotechnology company that develops large-scale insect breeding and processing processes. It sells ingredients derived from insects for animal nutrition and aquaculture.
3
Funding Rounds
$14.4m
Money raised
Meiogenix is a Île-de-France-based company founded in 2010 by Giacomo Bastianelli.
5
Funding Rounds
$234.9m
Money raised
A company in the insect processing, production, or supply industry.
2
Funding Rounds
$43.9m
Money raised
Novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line pre-loaded with peptides
2
Funding Rounds
$33.7m
Money raised
Qubit Pharmaceuticals is an international company that emerged from CNAM, CNRS, University of Texas at Austin, Sorbonne University and Washington University.
3
Funding Rounds
$36.2m
Money raised
French biotechnology company that usesprecision fermentation to produce real dairy products,accessible to everyone
3
Funding Rounds
$4.2m
Money raised
Research company focused on developing cancer treatments with STING agonists.
1
Funding Rounds
$3.0m
Money raised
Novadiscovery is an in silico Prediction of Drug Efficacy founded in 2010 by Jean-Pierre Boissel, François-Henri Boissel and Frédéric Cogny.
1
Funding Rounds
$2.8m
Money raised
Qynapse provides an FDA-Cleared neuroimaging software platform.
4
Funding Rounds
$767.0m
Money raised
Vivet Therapeutics is a gene Therapy for Orphan Diseases founded in 2016 by Jean-Philippe Combal.
3
Funding Rounds
$19.9m
Money raised
Pharnext is a very well advanced clinical-stage biopharmaceutical company
2
Funding Rounds
$220.0m
Money raised
Amolyt Pharma is a therapeutic Peptides founded in 2015.
1
Funding Rounds
$38.0m
Money raised
Sensorion is an inner ear disease treatments founded in 2009.
2
Funding Rounds
$10.7m
Money raised
Damae Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.
1
Funding Rounds
Nell Natural Elements is an artificial Intelligence company founded in 2017 by Geoff Webb.
1
Funding Rounds
$3.1m
Money raised
Developer of innovative peptides designed to offer targeted therapies for severe diseases, with an initial focus on oncology. The company's peptides are active compounds that penetrate cells and block relevant intracellular protein interactions that offer intracellular delivery of targeted therapies.
2
Funding Rounds
$6.0m
Money raised
Poietis is a biotechnology company that specializes in the design and development of regenerative medicine therapies.
1
Funding Rounds
$8.3m
Money raised
Exeliom is a gut microbiome modifiers founded by Benjamin Hadida, Harry Sokol, Patrick Gervais and Philippe Langella.
Enter your email and get access to 71,000 + technology companies you can partner with.